Citation

Please cite as:

Shkarupeta E

Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

JMIRx Med 2025;6:e77627

DOI: 10.2196/77627

PMCID: 12236262

Current Preprint Settings

(as selected by the authors)

1. When the manuscript is submitted, allow peer review from:

(a) Anybody (open community peer review)
(b) Editor-selected reviewers (closed peer review)

2. When the manuscript is submitted, display the preprint PDF to:

(a) Anybody, anytime
(b) Logged-in users only
(c) Anybody, anytime (title and abstract only)
(d) No one

3. When the manuscript is accepted, display the accepted manuscript PDF to:

(a) Anybody, anytime
(b) Logged-in users only
(c) Anybody, anytime (title and abstract only)
(d) No one

Accepted for/Published in: JMIRx Med

Date Submitted: May 16, 2025

Date Accepted: May 16, 2025

The final, peer-reviewed published version of this preprint can be found here:

Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Shkarupeta E

Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

JMIRx Med 2025;6:e77627

DOI: 10.2196/77627

PMCID: 12236262

Accepted Manuscript

JMIR Publications

JMIR Preprints

Accepted for/Published in: JMIRx Med

Date Submitted: May 16, 2025

Date Accepted: May 16, 2025

JMIR Preprints

Accepted for/Published in: JMIRx Med

Date Submitted: May 16, 2025

Date Accepted: May 16, 2025

Per the author's request this version is not available.